These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 28097236)

  • 1. Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli.
    Bennewitz MF; Jimenez MA; Vats R; Tutuncuoglu E; Jonassaint J; Kato GJ; Gladwin MT; Sundd P
    JCI Insight; 2017 Jan; 2(1):e89761. PubMed ID: 28097236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet Extracellular Vesicles Drive Inflammasome-IL-1β-Dependent Lung Injury in Sickle Cell Disease.
    Vats R; Brzoska T; Bennewitz MF; Jimenez MA; Pradhan-Sundd T; Tutuncuoglu E; Jonassaint J; Gutierrez E; Watkins SC; Shiva S; Scott MJ; Morelli AE; Neal MD; Kato GJ; Gladwin MT; Sundd P
    Am J Respir Crit Care Med; 2020 Jan; 201(1):33-46. PubMed ID: 31498653
    [No Abstract]   [Full Text] [Related]  

  • 3. P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease.
    Polanowska-Grabowska R; Wallace K; Field JJ; Chen L; Marshall MA; Figler R; Gear AR; Linden J
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2392-9. PubMed ID: 21071696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-to-lung microembolic NETs promote gasdermin D-dependent inflammatory lung injury in sickle cell disease.
    Vats R; Kaminski TW; Brzoska T; Leech JA; Tutuncuoglu E; Katoch O; Jonassaint J; Tejero J; Novelli EM; Pradhan-Sundd T; Gladwin MT; Sundd P
    Blood; 2022 Sep; 140(9):1020-1037. PubMed ID: 35737916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LPS-induced Lung Platelet Recruitment Occurs Independently from Neutrophils, PSGL-1, and P-Selectin.
    Cleary SJ; Hobbs C; Amison RT; Arnold S; O'Shaughnessy BG; Lefrançais E; Mallavia B; Looney MR; Page CP; Pitchford SC
    Am J Respir Cell Mol Biol; 2019 Aug; 61(2):232-243. PubMed ID: 30768917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of prasugrel on ADP-stimulated markers of platelet activation in patients with sickle cell disease.
    Jakubowski JA; Zhou C; Winters KJ; Lachno DR; Howard J; Payne CD; Mant T; Jurcevic S; Frelinger AL
    Platelets; 2015; 26(5):474-9. PubMed ID: 25140584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Neutrophil Adhesive Events to Address Vaso-Occlusive Crisis in Sickle Cell Patients.
    Morikis VA; Hernandez AA; Magnani JL; Sperandio M; Simon SI
    Front Immunol; 2021; 12():663886. PubMed ID: 33995392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial TLR4 Expression Mediates Vaso-Occlusive Crisis in Sickle Cell Disease.
    Beckman JD; Abdullah F; Chen C; Kirchner R; Rivera-Rodriguez D; Kiser ZM; Nguyen A; Zhang P; Nguyen J; Hebbel RP; Belcher JD; Vercellotti GM
    Front Immunol; 2020; 11():613278. PubMed ID: 33542720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative intravital two-photon excitation microscopy reveals absence of pulmonary vaso-occlusion in unchallenged Sickle Cell Disease mice.
    Bennewitz MF; Watkins SC; Sundd P
    Intravital; 2014 Jul; 3(2):e29748. PubMed ID: 25995970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tandem P-selectin glycoprotein ligand immunoglobulin prevents lung vaso-occlusion in sickle cell disease mice.
    Vats R; Tutuncuoglu E; Pradhan-Sundd T; Tejero J; Shaw GD; Sundd P
    Exp Hematol; 2020 Apr; 84():1-6.e1. PubMed ID: 32243995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sickle cell disease as a vascular disorder.
    Ofori-Acquah SF
    Expert Rev Hematol; 2020 Jun; 13(6):645-653. PubMed ID: 32362160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of C5a in sickle cell disease.
    Vercellotti GM; Dalmasso AP; Schaid TR; Nguyen J; Chen C; Ericson ME; Abdulla F; Killeen T; Lindorfer MA; Taylor RP; Belcher JD
    Am J Hematol; 2019 Mar; 94(3):327-337. PubMed ID: 30569594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.
    Belcher JD; Chen C; Nguyen J; Milbauer L; Abdulla F; Alayash AI; Smith A; Nath KA; Hebbel RP; Vercellotti GM
    Blood; 2014 Jan; 123(3):377-90. PubMed ID: 24277079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase 1 study of prasugrel in patients with sickle cell disease: effects on biomarkers of platelet activation and coagulation.
    Jakubowski JA; Zhou C; Jurcevic S; Winters KJ; Lachno DR; Frelinger AL; Gupta N; Howard J; Payne CD; Mant TG
    Thromb Res; 2014 Feb; 133(2):190-5. PubMed ID: 24368019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pulmonary ischemia-reperfusion on platelet adhesion in subpleural arterioles in rabbits.
    Roberts AM; Ovechkin AV; Mowbray JG; Robinson TW; Lominadze D
    Microvasc Res; 2004 Jan; 67(1):29-37. PubMed ID: 14709400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin activation of PAR-1 contributes to microvascular stasis in mouse models of sickle cell disease.
    Sparkenbaugh EM; Chen C; Brzoska T; Nguyen J; Wang S; Vercellotti GM; Key NS; Sundd P; Belcher JD; Pawlinski R
    Blood; 2020 May; 135(20):1783-1787. PubMed ID: 31977004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activation biomarkers in Berkeley sickle cell mice and the response to prasugrel.
    Ohno K; Tanaka H; Samata N; Jakubowski JA; Tomizawa A; Mizuno M; Sugidachi A
    Thromb Res; 2014 Oct; 134(4):889-94. PubMed ID: 25130912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary alpha-linolenic acid reduces platelet activation and collagen-mediated cell adhesion in sickle cell disease mice.
    Stivala S; Gobbato S; Bonetti N; Camici GG; Lüscher TF; Beer JH
    J Thromb Haemost; 2022 Feb; 20(2):375-386. PubMed ID: 34758193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.
    Heeney MM; Hoppe CC; Abboud MR; Inusa B; Kanter J; Ogutu B; Brown PB; Heath LE; Jakubowski JA; Zhou C; Zamoryakhin D; Agbenyega T; Colombatti R; Hassab HM; Nduba VN; Oyieko JN; Robitaille N; Segbefia CI; Rees DC;
    N Engl J Med; 2016 Feb; 374(7):625-35. PubMed ID: 26644172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ARQ 092, an orally-available, selective AKT inhibitor, attenuates neutrophil-platelet interactions in sickle cell disease.
    Kim K; Li J; Barazia A; Tseng A; Youn SW; Abbadessa G; Yu Y; Schwartz B; Andrews RK; Gordeuk VR; Cho J
    Haematologica; 2017 Feb; 102(2):246-259. PubMed ID: 27758820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.